BSE Live
Nov 14, 16:01Prev. Close
266.95
Open Price
267.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 14, 15:48Prev. Close
267.25
Open Price
267.25
Bid Price (Qty.)
262.90 (40)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Indoco Remedies (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Jun 07 | Jun 06 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 34.26 | 25.59 | 24.49 | 35.56 | 24.01 | |
| Diluted EPS (Rs.) | 34.26 | 25.59 | 24.49 | 35.56 | 24.01 | |
| Cash EPS (Rs.) | 44.18 | 34.91 | 31.02 | 43.91 | 30.00 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 252.72 | 226.62 | 206.93 | 196.71 | 165.21 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 252.72 | 226.62 | 206.93 | 196.72 | 165.21 | |
| Dividend / Share(Rs.) | 7.00 | 5.25 | 5.00 | 6.50 | 6.25 | |
| Revenue from Operations/Share (Rs.) | 328.85 | 285.15 | 213.70 | 274.93 | 204.53 | |
| PBDIT/Share (Rs.) | 47.31 | 40.52 | 36.80 | 52.66 | 41.52 | |
| PBIT/Share (Rs.) | 37.46 | 31.44 | 30.47 | 45.02 | 36.48 | |
| PBT/Share (Rs.) | 35.10 | 26.69 | 27.52 | 40.72 | 33.50 | |
| Net Profit/Share (Rs.) | 34.26 | 25.59 | 24.49 | 35.56 | 24.01 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 14.38 | 14.21 | 17.22 | 19.15 | 20.29 | |
| PBIT Margin (%) | 11.39 | 11.02 | 14.25 | 16.37 | 17.83 | |
| PBT Margin (%) | 10.67 | 9.35 | 12.87 | 14.81 | 16.37 | |
| Net Profit Margin (%) | 10.41 | 8.97 | 11.46 | 12.93 | 11.73 | |
| Return on Networth / Equity (%) | 13.55 | 11.29 | 11.83 | 18.07 | 14.53 | |
| Return on Capital Employed (%) | 11.04 | 9.41 | 10.29 | 15.71 | 12.58 | |
| Return on Assets (%) | 8.76 | 7.53 | 8.03 | 12.06 | 9.35 | |
| Total Debt/Equity (X) | 0.21 | 0.20 | 0.13 | 0.15 | 0.17 | |
| Asset Turnover Ratio (%) | 84.11 | 83.95 | 70.10 | 93.27 | 79.67 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.53 | 2.68 | 2.42 | 2.20 | 2.32 | |
| Quick Ratio (X) | 1.83 | 2.05 | 1.88 | 1.73 | 1.90 | |
| Inventory Turnover Ratio (X) | 5.83 | 6.68 | 5.92 | 8.56 | 7.37 | |
| Dividend Payout Ratio (NP) (%) | 20.43 | 20.51 | 20.41 | 18.99 | 26.03 | |
| Dividend Payout Ratio (CP) (%) | 15.84 | 15.03 | 16.11 | 15.38 | 20.83 | |
| Earnings Retention Ratio (%) | 79.57 | 79.49 | 79.59 | 81.01 | 73.97 | |
| Cash Earnings Retention Ratio (%) | 84.16 | 84.97 | 83.89 | 84.62 | 79.17 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 519.29 | 195.04 | 370.76 | 350.01 | 308.37 | |
| EV/Net Operating Revenue (X) | 1.29 | 0.56 | 1.41 | 1.08 | 1.28 | |
| EV/EBITDA (X) | 8.93 | 3.92 | 8.20 | 5.62 | 6.28 | |
| MarketCap/Net Operating Revenue (X) | 1.21 | 0.48 | 1.34 | 1.01 | 1.24 | |
| Retention Ratios (%) | 79.56 | 79.48 | 79.58 | 81.00 | 73.96 | |
| Price/BV (X) | 1.58 | 0.61 | 1.39 | 1.42 | 1.53 | |
| Price/Net Operating Revenue | 1.21 | 0.48 | 1.34 | 1.01 | 1.24 | |
| Earnings Yield | 0.09 | 0.19 | 0.09 | 0.13 | 0.09 |
12.11.2025
Indoco Remedies Standalone September 2025 Net Sales at Rs 442.12 crore, up 11.5% Y-o-Y
07.11.2025
Indoco Remedies Consolidated September 2025 Net Sales at Rs 484.67 crore, up 12.02% Y-o-Y
25.07.2025
24.07.2025
Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y
12.11.2025
Indoco Remedies Standalone September 2025 Net Sales at Rs 442.12 crore, up 11.5% Y-o-Y
07.11.2025
Indoco Remedies Consolidated September 2025 Net Sales at Rs 484.67 crore, up 12.02% Y-o-Y
24.07.2025
Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y
24.07.2025
Indoco Remedies Standalone June 2025 Net Sales at Rs 392.53 crore, down 2.22% Y-o-Y
12.07.2023
Indoco Remedies Q1 PAT may dip 0.1% YoY to Rs 38.5 cr: Nirmal Bang
17.01.2023
Indoco Remedies Q3 PAT seen up 46.1% YoY to Rs 482 cr: Nirmal Bang
08.07.2022
Indoco Remedies Q1 PAT seen up 4.4% YoY to Rs 41.4 cr: Prabhudas Lilladher
14.04.2022
Indoco Remedies Q4 PAT seen up 52.9% YoY to Rs 38.2 cr: Prabhudas Lilladher